FDA NDC Directory · JSON-LD · Markdown

Mesalamine

NDC 67877-717 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA214242
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsMESALAMINE (.375 g/1)
Marketing started20210716
Package count2

External sources

Source: openFDA. Public-domain (CC0).